Navigation Links
Lens Wearers Alerted Over Dangerous Fungal Infection

Following high incidence of a potentially dangerous infection associated with use of ReNu MoistureLoc lens solution, manufactured by Bausch & Lomb//, those in Hong Kong, US and Singapore have been alerted regarding the same and the controversial product has been withdrawn from sales.

Preliminary investigations have not revealed any contamination of the product. However the company has been unable to claim that the product is safe to use. All users have therefore been requested to stop using the product by the UK regulatory authority.

Alternatively users of this eye care product have been urged to discard any remaining solution in the bottle and get the empty bottle exchanged for some other lens care solution at the sales counter. This precautionary measure would prevent a majority of the rare fungal infection that can eventually lead to blindness, according to the Medicines and Healthcare products Regulatory Authority (MHRA).

‘After an extensive investigation involving thousands of tests, millions of dollars and collaboration with government agencies, health authorities and independent experts, there is no evidence of product contamination, tampering, counterfeiting or sterility failure. That leads us to conclude that some aspect of the MoistureLoc formula may be increasing the relative risk of Fusarium infection in unusual circumstances,’ said Ronald Zarrella, chief executive officer of Bausch & Lomb.

Fusarium infections can lead to inflammation of the front part of the eye, the cornea, characterized by symptoms of redness, blurred vision, swelling, pain, abnormal sensitivity to light and tearing.


'"/>




Page: 1

Related medicine news :

1. Tattoo Wearers Are More Prone To Allergy Risks
2. Alarm Raised for Contact Lens Wearers
3. Snorers, Tattoo Wearers Out From Chinese Army
4. Reports Characterize Fungal Eye Infections Among Soft Contact Lens Wearers
5. Women Alerted against "Natural Hormone Replacement Therapy"
6. Meningitis C Surfaces in Toronto:Public Alerted
7. Antibiotics Dangerous for Diarrhoea in Children Caused by E.Coli
8. Dangerous food bacteria
9. Breaking up Dangerous Clots
10. Weight-loss Products Dangerous
11. Human Growth Hormone Found To be Dangerous For Human Use
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Lens Wearers Alerted Over Dangerous Fungal Infection

(Date:8/3/2015)... ... ... AxoGen, Inc. (NASDAQ: AXGN), a leader in developing and marketing innovative surgical solutions ... Wednesday, August 12, 2015 at 9:45am (ET) at Le Parker Meridien in New York, ... be accessed via the investor relations section of the Company’s website. , About AxoGen, ...
(Date:8/3/2015)... ... August 03, 2015 , ... A July 9 article from USA ... recent years, according to the American Dental Association. According to a study by the ... from 1.1 million in a single year to 2.2 million a year. Dentists and ...
(Date:8/3/2015)... ... August 03, 2015 , ... Dignity Health named Dr. ... General Hospital Emergency Room – Gilbert, opening in August. The new facility is ... in the West Valley. , “Dr. Baldwin is an excellent leader and will ...
(Date:8/3/2015)... Spring, MD (PRWEB) , ... August 03, 2015 , ... ... the addition of a new associate podiatrist, creating the largest medical practice in the ... foot and ankle medicine. FASMA operates 21 locations with 33 doctors. , Dr. Hetal ...
(Date:8/3/2015)... Louisville, KY (PRWEB) , ... August 03, 2015 , ... ... suffer from lower back pain at least once in their lives. Often time, low ... bulges. Until recently, disc herniations could only be managed clinically with powerful pain medication ...
Breaking Medicine News(10 mins):Health News:AxoGen, Inc. to Present at the Wedbush Healthcare Conference 2Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 2Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 3Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 2Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 3Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 2Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 3Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 4Health News:Dynamic Health Care in Louisville, KY, Offers a New and Cutting-Edge Therapy for Low Back & Leg Pain Sufferers 2
... (August 15, 2011) Documenting the hazards of lead ... study in the September issue of the Journal ... living near these facilities in developing countries had approximately ... children. The researchers, using data from studies published ...
... Although many children anxiously anticipate the first day of school, ... Children who are excessively worried for a prolonged period ... "Even though most children are anxious during a time ... the new school within two weeks. But if a child ...
... By Randy Dotinga HealthDay Reporter , FRIDAY, ... men who undergo prostate removal often suffer more from ... beforehand about possible aftereffects. The findings suggest there,s ... expect post-surgery and what actually happens -- and that ...
... The U.S. Department of Health and Human Services (HHS) and ... states and the District of Columbia to speed up creation ... health care reform -- across the country. The agencies ... include tax relief to give families and small businesses "the ...
... 12 (HealthDay News) -- Although being physically active is one ... and improve their ability to get around, a new study ... sedentary than previously thought. Researchers from Northwestern University Feinberg ... and 40 percent of men with knee osteoarthritis are basically ...
... American Journal of Industrial Medicine reveals that the ... City Fire Department (FDNY) resulting in more post-9/11 retirements ... Chief Medical Officer, FDNY, researchers assessed a total of ... 10, 2008, comparing the total number of retirements and ...
Cached Medicine News:Health News:Lead poisoning from battery industry reported in developing countries 2Health News:Planning Ahead Can Reduce Back-to-School Stress 2Health News:Many Men Underestimate Prostate Surgery Side Effects 2Health News:Many Men Underestimate Prostate Surgery Side Effects 3Health News:Feds Outline Rules for States' Insurance Exchanges 2Health News:Many Arthritis Patients May Not Be Exercising Enough 2
(Date:8/3/2015)... and FLORHAM PARK, N.J. , Aug. ... naldemedine met its primary and secondary endpoints in a ... opioid-induced constipation (OIC) in adult patients with chronic non-cancer ... receptor antagonist (PAMORA). This is the third Phase III ... secondary endpoints. Study results showed that a ...
(Date:8/3/2015)... 3, 2015 Shire plc ... that it has acquired New York ... $300 million. With the acquisition, Shire acquires the ... 0.6% povidone iodine (PVP-I) and 0.1% dexamethasone), a ... infectious conjunctivitis, an ocular surface condition commonly referred ...
(Date:7/31/2015)... 2015  Physicians and payers alone do not ... Patients are better informed and getting increasingly involved ... This shift in power is reshaping the healthcare ... marketing. As part of this evolving ... important to educate, communicate and engage patients throughout ...
Breaking Medicine Technology:Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 4Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 2Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 3Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 4Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 5Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 6Consumers Forcing Pharmaceutical Industry to Shift its Marketing Focus from Products to Patients 2
... Aug. 18, 2011 A national analysis conducted ... North America, Inc., identified Columbus, Ohio, as one ... that have hypertension risk factors and complications. The ... of a larger Takeda-sponsored hypertension awareness program called ...
... 18, 2011 Reportlinker.com announces that a ... its catalogue: China ... http://www.reportlinker.com/p0590608/China-Contract-Research-Organization-CRO-Industry-Report-2010-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Disc ... high R&D costs of new drugs worldwide, ...
Cached Medicine Technology:Columbus Included in Analysis of Top Hypertension Hot Spots in the United States 2Columbus Included in Analysis of Top Hypertension Hot Spots in the United States 3Columbus Included in Analysis of Top Hypertension Hot Spots in the United States 4China Contract Research Organization (CRO) Industry Report, 2010-2011 2China Contract Research Organization (CRO) Industry Report, 2010-2011 3China Contract Research Organization (CRO) Industry Report, 2010-2011 4China Contract Research Organization (CRO) Industry Report, 2010-2011 5
... VitalWorks Intuition EMR family of ... for a range of specialties. Intuition ... review the full electronic record at ... physicians to spend less time on ...
... hunt for a patient's folder again. The ... and more are all completely accessible from ... is an effective and affordable charting solution ... user in mind, Charting Plus EMR relies ...
... PM Ophthalmology, VitalWorks OptiShop simpli?es ... shop. From ordering to inventory ... OptiShop is designed to address ... todays optical shops, and to ...
Compulink is among today's leaders in the ophthalmic practice management market. Compulink's Ophthalmology Advantage integrates all the functionality of a busy Ophthalmic practice needs, while keepin...
Medicine Products: